VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
+3.75%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$57.2M
AUM Growth
+$57.2M
(-41%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-47.87%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$619K |
Sector Composition
| 1 | Healthcare | 44.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
VYNE Therapeutics
VYNE
$8.16M
| $14.4M | 25.18% | 1,461,552 | – | – |
|
|
VRNA
2
Verona Pharma
VRNA
$9.16B
| $10.9M | 19.15% | 875,000 | – | – |
|
|
NBRV
3
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| – | – | -177,957 | Closed | -$619K |
|